Literature DB >> 6631170

The role of reactive oxygen species in thromboxane b2 generation by polymorphonuclear leukocytes.

M L Segal, R H Fertel, E H Kraut, A L Sagone.   

Abstract

These studies evaluated further the relationship between the metabolism of reactive oxygen species (ROS) and prostaglandins in human granulocytes. Our experiments examined (1) the effects of several scavengers of ROS on thromboxane B2 (TXB2) production by zymosan-stimulated PMNs, (2) the capacity of the granulocytes of patients with chronic granulomatous disease (CGD) to produce TXB2, and finally (3) the generation of oxygen radicals in PMNs stimulated to produce TXB2 by the enzyme phospholipase A2. Our results confirm that both zymosan- and PMA-stimulated PMNs release increased amounts of TXB2. This enhanced production of TXB2 by normal PMNs could not be impaired and, in fact, appeared to be enhanced by scavengers of ROS. The PMNs of one patient with CGD produced TXB2 in an amount similar to those of healthy persons, whereas the TXB2 produced by the PMNs of a second patient was markedly increased. Finally, the enzyme phospholipase A2 stimulated TXB2 production in PMNs without stimulating the production of ROS. These data indicate that the activation of prostaglandin metabolism in PMNs is not dependent on the simultaneous production of ROS by these cells. However, the simultaneous production of ROS may be associated with an alteration of prostaglandin metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631170

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Effect of diethyldithiocarbamate (DDC) on human monocyte function and metabolism.

Authors:  P Conkling; D G Cornwell; A L Sagone
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

2.  Pulmonary edema after aneurysm surgery is modified by mannitol.

Authors:  I S Paterson; J M Klausner; G Goldman; R Pugatch; H Feingold; P Allen; J A Mannick; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

3.  The effects of the anti-tumor agent mezerein on the cytotoxic capacity and oxidative metabolism of human blood cells.

Authors:  K Barton; G Randall; A L Sagone
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.